Medication info

Carnitin Injection (L-Carnitine)

Prescription medicationIntravenous injection
Ingredient · strength
L-Carnitine›200mg / 1mL
Manufacturer / importer
Albozen Korea Co., Ltd.
Appearance
A clear liquid ranging from colorless to pale yellow in a brown ampoule
Packaging
5ml / ampoule x 10
Approval status
Active

MFDS item code 200403324 · Notified 2004.05.06

Summary

Main use
Treatment of carnitine deficiency (e.g., in dialysis patients) and myocardial metabolic disorders associated with ischemic heart disease
Who receives it
Adults
Adult administration
1. Primary and secondary carnitine deficiency Myocardial metabolic disorder due to ischemic heart disease: angina, acute myocardial infarction Adults: Administer 2~3 grams of L-carnitine daily in 2~3 divided doses by intramuscular or intravenous injection. Adjust the dose as appropriate according to age and symptoms. 2. Treatment of carnitine deficiency in patients with end-stage renal disease undergoing hemodialysis Initially, administer 10~20 milligrams/kilogram intravenously over 2~3 minutes at the end of each hemodialysis session. The dose may be adjusted according to the plasma L-carnitine level before hemodialysis.

Ingredients

Manufacturer
Albozen Korea Co., Ltd.

Efficacy & effects

Treatment of carnitine deficiency (e.g., in dialysis patients) and myocardial metabolic disorders associated with ischemic heart disease

  • Primary carnitine deficiency
  • secondary carnitine deficiency
  • angina
  • acute myocardial infarction
  • carnitine deficiency in patients with end-stage kidney disease
View approved original text

This medication is used to treat primary and secondary carnitine deficiency. It also helps improve myocardial metabolic disorders due to ischemic heart disease, such as angina and acute myocardial infarction. It is effective for treating carnitine deficiency in patients with end-stage kidney disease undergoing hemodialysis. Thus, it is used to improve carnitine deficiency associated with major cardiovascular diseases and kidney diseases.

How it is given

Adult administration

1. Primary and secondary carnitine deficiency Myocardial metabolic disorder due to ischemic heart disease: angina, acute myocardial infarction Adults: Administer 2~3 grams of L-carnitine daily in 2~3 divided doses by intramuscular or intravenous injection. Adjust the dose as appropriate according to age and symptoms. 2. Treatment of carnitine deficiency in patients with end-stage renal disease undergoing hemodialysis Initially, administer 10~20 milligrams/kilogram intravenously over 2~3 minutes at the end of each hemodialysis session. The dose may be adjusted according to the plasma L-carnitine level before hemodialysis.

Precautions

This medication should be handled carefully as glass pieces may mix when cutting the injection container. Extra caution is especially needed when children or the elderly use it. Patients who have an allergic reaction to this medication should not use it. Temporary nausea or vomiting may occur, and rarely, changes in body odor or gastritis may appear. Patients with a history of seizures may experience seizures more frequently or severely, so caution is advised. Various side effects have been reported in chronic hemodialysis patients, including abdominal pain, allergic reactions, headaches, heart-related issues, and digestive disorders. Additionally, symptoms such as skin rashes, muscle pain, anxiety, dizziness, and respiratory distress may also occur. Women who are pregnant or may become pregnant should use this medication only if the benefits outweigh the risks, as its safety is not assured. Caution is also advised for nursing mothers since the medication may transfer to breast milk.

Side effects

  • Temporary area
  • vomiting
  • body odor
  • gastritis
  • seizures
  • abdominal pain
  • accidental injury
  • allergic reactions
  • asthma
  • low back pain
Show 50 more
  • chest pain
  • fever
  • flu syndrome
  • headache
  • infection
  • injection site reaction
  • pain
  • arrhythmia
  • ventricular fibrillation
  • cardiovascular disease
  • abnormal electrocardiogram
  • bleeding
  • hypertension
  • hypotension
  • palpitations
  • tachycardia
  • anemia
  • hypercalcemia
  • hyperkalemia
  • hypervolemia
  • peripheral edema
  • weight loss
  • weight gain
  • leg cramps
  • myalgia
  • anxiety
  • depression
  • dizziness
  • drug dependence
  • increased tension
  • insomnia
  • sensory disturbances
  • vertigo
  • bronchitis
  • increased cough
  • dyspnea
  • pharyngitis
  • respiratory diseases
  • rhinitis
  • sinusitis
  • pruritus
  • rash
  • amblyopia
  • eye diseases
  • taste disturbances
  • urinary tract infection
  • kidney failure
  • urticaria
  • facial swelling
  • myasthenia gravis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a container that does not allow light to enter. It is best to store it at room temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

A clear liquid ranging from colorless to pale yellow in a brown ampoule

Package unit

5ml / ampoule x 10

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.